Voyager Therapeutics (VYGR) Share-based Compensation Growth (1y) (2015 - 2026)
Voyager Therapeutics (VYGR) Share-based Compensation Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -40.86% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Voyager Therapeutics | 184.74 Mn | 43.26 Mn | - | -32.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.26% |
| Dec 31, 2025 | 3.13% |
| Sep 30, 2025 | 3.13% |
| Jun 30, 2025 | 4.40% |
| Mar 31, 2025 | 5.00% |
| Dec 31, 2024 | 23.74% |
| Sep 30, 2024 | 16.57% |
| Jun 30, 2024 | 50.70% |
| Mar 31, 2024 | 39.70% |
| Dec 31, 2023 | 28.03% |
| Sep 30, 2023 | 36.66% |
| Jun 30, 2023 | 6.79% |
| Mar 31, 2023 | 10.41% |
| Dec 31, 2022 | 124.62% |
| Sep 30, 2022 | 4.00% |
| Jun 30, 2022 | -36.45% |
| Mar 31, 2022 | -35.16% |
| Dec 31, 2021 | -385.36% |
| Sep 30, 2021 | -41.07% |
| Jun 30, 2021 | 2.00% |